IUPAC Selects Glycan Trimming Technology used in Uvax Bio’s HIV-1 Vaccine Design and Manufacturing as one of the Top Ten Emerging Technologies in Chemistry for 2023
The IUPAC described this technology as “low-sugar vaccinations.”
- The IUPAC described this technology as “low-sugar vaccinations.”
Glycans are long, branched sugar molecules that are commonly attached to viral surface proteins. - But the glycan coating can also contribute to the immune response.
- Finally, Zhu decided to remove most (but not all) of the glycan shield through an enzymatic process.
- “We congratulate Prof. Zhu and his team at Scripps Research on this recognition of their innovative work in HIV vaccine design and chemistry.